Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Wellington Management Group LLP

Wellington Management Group LLP raised its stake in Progyny, Inc. (NASDAQ:PGNY) by 4.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 430,300 shares of the company’s stock after acquiring an additional 16,638 shares during the quarter. Wellington Management Group LLP’s holdings in Progyny were worth $7,212,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Quarry LP increased its holdings in shares of Progyny by 1,900.0% during the 2nd quarter. Quarry LP now owns 880 shares of the company’s stock valued at $25,000 after purchasing an additional 836 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in Progyny in the second quarter valued at $44,000. Mendota Financial Group LLC purchased a new position in Progyny in the third quarter valued at $56,000. 1620 Investment Advisors Inc. acquired a new position in shares of Progyny in the second quarter worth about $97,000. Finally, nVerses Capital LLC boosted its stake in shares of Progyny by 925.0% during the 2nd quarter. nVerses Capital LLC now owns 4,100 shares of the company’s stock worth $117,000 after acquiring an additional 3,700 shares in the last quarter. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on PGNY shares. Barclays reduced their price target on Progyny from $30.00 to $17.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $17.00 target price (down previously from $22.00) on shares of Progyny in a research report on Monday, December 2nd. JMP Securities lowered shares of Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $25.00 price objective on shares of Progyny in a report on Tuesday, October 1st. Finally, Bank of America cut their target price on shares of Progyny from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Nine analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $25.00.

Progyny Stock Up 1.9 %

Shares of NASDAQ:PGNY opened at $14.89 on Tuesday. Progyny, Inc. has a 52-week low of $13.39 and a 52-week high of $42.08. The business has a fifty day moving average of $15.51 and a two-hundred day moving average of $21.22. The stock has a market cap of $1.27 billion, a P/E ratio of 25.67, a PEG ratio of 1.64 and a beta of 1.35.

Progyny (NASDAQ:PGNY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $286.63 million for the quarter, compared to analyst estimates of $296.85 million. Progyny had a return on equity of 11.36% and a net margin of 5.03%. Progyny’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.16 earnings per share. On average, equities analysts anticipate that Progyny, Inc. will post 0.59 earnings per share for the current year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.